Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Abstract

Worldwide, endometrial cancer (EC) ranks seventh among all female cancers with the majority of cases occurring between 65 and 75 years of age.1 In Europe, uterine cancer ranks fourth among female neoplasms, with an incidence of 12.9-20.2:100 000 and a low mortality rate: 2.0-2.7:100 000.2,3 This discrepancy is due to the fact that 80% of ECs are confined to the uterus at diagnosis and present with postmenopausal bleeding, which leads to prompt detection.1

Cervical cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
D. Lorusso, D. Cibula, I. Colombo +13
ESMO Open24 Sep 2026Peer-reviewedCC BY-NC-ND 4.0Full text1 citedObstetrics, gynaecology & paediatricsPMC
Update of the Brazilian Clinical Practice Guideline for primary immune thrombocytopenia: methodological process and main changes for diagnosis and treatment in the Brazilian Unified Health System (SUS)
Ludmila Peres Gargano, Tassiane Cristine Santos de Paula, Layssa Andrade Oliveira +8
Hematology, Transfusion and Cell Therapy27 Oct 2026Peer-reviewedCC BY 4.0Full textGeneral medicinePMC
Antenatal diagnosis and classification for placenta accreta (adherence) spectrum: Clinical practice guideline and recommendations by the World Association of Perinatal Medicine and the Perinatal Medicine Foundation.
Andrea Dall'Asta, Cihat Sen, Rozi Aryananda +9
Pregnancy (Hoboken, N.J.)24 Oct 2026Peer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsEurope PMCDOAJ
Artificial intelligence-assisted bronchoscopy for the diagnosis and treatment of pulmonary diseases: Advances and clinical practice
Guoliang Zhang, Yidan Qing, Xianwen Sun +5
Journal of translational internal medicine23 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCEurope PMCPMC
Newly diagnosed and relapsed follicular lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.
Marco Ladetto, Natacha Bolaños, Guy Bouguet +15
HemaSphere19 Oct 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeX RIS

BibTeX

@article{oaknin2026endometrial,
  title = {{Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up}},
  author = {A. Oaknin and T.J. Bosse and C.L. Creutzberg and G. Giornelli and P. Harter and F. Joly and D. Lorusso and C. Marth and V. Makker and M.R. Mirza and J.A. Ledermann and N. Colombo},
  journal = {Annals of Oncology},
  year = {2026},
  month = sep,
  doi = {10.1016/j.annonc.2022.05.009},
  url = {https://hal.science/hal-05765934v1},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
AU  - A. Oaknin
AU  - T.J. Bosse
AU  - C.L. Creutzberg
AU  - G. Giornelli
AU  - P. Harter
AU  - F. Joly
AU  - D. Lorusso
AU  - C. Marth
AU  - V. Makker
AU  - M.R. Mirza
AU  - J.A. Ledermann
AU  - N. Colombo
PY  - 2026
DA  - 2026/09/27
JO  - Annals of Oncology
DO  - 10.1016/j.annonc.2022.05.009
UR  - https://hal.science/hal-05765934v1
AB  - Worldwide, endometrial cancer (EC) ranks seventh among all female cancers with the majority of cases occurring between 65 and 75 years of age.1 In Europe, uterine cancer ranks fourth among female neoplasms, with an incidence of 12.9-20.2:100 000 and a low mortality rate: 2.0-2.7:100 000.2,3 This discrepancy is due to the fact that 80% of ECs are confined to the uterus at diagnosis and present with postmenopausal bleeding, which leads to prompt detection.1
SN  - 0923-7534
SN  - 1569-8041
ER  -

Abstract

Related

Cite